Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
CancerPain Management

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1507233

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1507233

Cancer Pain Management Market Share, Size, Trends, Industry Analysis Report, By Pain Type (Acute Pain, Chronic Pain); By Drug Type; By Cancer Type; By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032

PUBLISHED:
PAGES: 117 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

Description

Table of Contents

List of Tables

The global cancer pain management market size is expected to reach USD 8.39 billion by 2032, according to a new study by Polaris Market Research. The report "Cancer Pain Management Market Share, Size, Trends, Industry Analysis Report, By Pain Type (Acute Pain, Chronic Pain); By Drug Type; By Cancer Type; By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The cancer pain management market is witnessing rapid growth. Cancer pain can range from mild to severe and present in various forms, such as sharp stabbing pain, tingling, burning sensation, or a persistent ache. The impact of cancer pain on your quality of life is significant, worsening cancer symptoms and treatment side effects. Additionally, it can heighten the likelihood of developing depression and anxiety. Therefore, proper pain management is crucial in cancer treatment.

Additionally, cancer care management services focus on optimizing symptom management, including pain control, throughout the cancer journey of the patient. They provide holistic and compassionate care tailored to each patient's unique needs and preferences. Effective cancer pain management requires a collaborative effort from oncologists, pain specialists, cancer care teams, nurses, social workers, and other healthcare professionals to address the complex and individualized needs of cancer patients.

In recent years, additional methods that could be beneficial in alleviating chronic pain include acupuncture. This traditional Chinese medicine practice entails the insertion and manipulation of thin needles into specific areas of the skin. While scientific research has demonstrated the effectiveness of acupuncture in treating certain types of pain, there is limited evidence regarding its efficacy in managing cancer-related pain. Transcutaneous electrical nerve stimulation (TENS) therapy involves the application of a low-level electrical current through electrodes placed on the skin, eliciting a response from the body that helps alleviate pain.

Cancer Pain Management Market Report Highlights

The opioids segment dominated the market, largely attributable to their property to alleviate moderate to severe pain.

The non-opioids drug segment is projected to grow at a CAGR during the projected period, mainly driven by its effectiveness in managing mild to moderate pain.

The lung cancer segment accounted for the largest market share, attributed to the rising prevalence of lung cancer, a higher frequency of pain related to lung cancer.

The hospitals segment dominated the market highly accelerated due to the increasing preference and trust of patients towards hospital settings.

The North America region dominated the market attributed to the increasing prevalence of cancer has created a greater demand for healthcare services.

The global key market players include BioDelivery Sciences, Daiichi Sankyo, Eli Lilly & Company, Endo Pharmaceuticals, Johnson & Johnson Inc., etc.

Polaris Market Research has segmented the cancer pain management market report based on pain type, drug type, cancer type, application, end-use, and region:

Cancer Pain Management, Pain Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Acute Pain
  • Chronic Pain

Cancer Pain Management, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Opioid
  • Morphine
  • Fentanyl
  • Others
  • Non-opioids
  • Non-steroidal anti-inflammatory drug
  • Acetaminophen
  • Corticosteroids
  • Anti-depressants
  • Anti-anxiety drugs
  • Anti-convulsant drugs
  • Nerve Blockers

Cancer Pain Management, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Lung Cancer
  • Colorectal cancer
  • Breast cancer
  • Prostate cancer
  • Blood cancer
  • Others

Cancer Pain Management, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Immunotherapy
  • Chemotherapy
  • Radiotherapy
  • Home Therapy
  • Others

Cancer Pain Management, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Cancer Care Clinics
  • Others

Cancer Pain Management, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa
Show more
Product Code: PM1320

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cancer Pain Management Market Insights

  • 4.1. Cancer Pain Management - Industry Snapshot
  • 4.2. Cancer Pain Management Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Geriatric Population
      • 4.2.1.2. Rising Technology in Cancer Pain Management
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Cancer Pain Management Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Cancer Pain Management Market, by Pain Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • 5.3. Acute Pain
    • 5.3.1. Global Cancer Pain Management Market, by Acute Pain, by Region, 2019-2032 (USD Billion)
  • 5.4. Chronic Pain
    • 5.4.1. Global Cancer Pain Management Market, by Chronic Pain, by Region, 2019-2032 (USD Billion)

6. Global Cancer Pain Management Market, by Drug Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • 6.3. Opioid
    • 6.3.1. Global Cancer Pain Management Market, by Opioid, by Region, 2019-2032 (USD Billion)
    • 6.3.2. Morphine
      • 6.3.2.1. Global Cancer Pain Management Market, by Morphine, by Region, 2019-2032 (USD Billion)
    • 6.3.3. Fentanyl
      • 6.3.3.1. Global Cancer Pain Management Market, by Fentanyl, by Region, 2019-2032 (USD Billion)
    • 6.3.4. Others
      • 6.3.4.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)
  • 6.4. Non-opioids
    • 6.4.1. Global Cancer Pain Management Market, by Non-opioids, by Region, 2019-2032 (USD Billion)
    • 6.4.2. Non-steroidal anti-inflammatory drug
      • 6.4.2.1. Global Cancer Pain Management Market, by Non-steroidal anti-inflammatory drug, by Region, 2019-2032 (USD Billion)
    • 6.4.3. Acetaminophen
      • 6.4.3.1. Global Cancer Pain Management Market, by Acetaminophen, by Region, 2019-2032 (USD Billion)
  • 6.5. Corticosteroids
    • 6.5.1. Global Cancer Pain Management Market, by Corticosteroids, by Region, 2019-2032 (USD Billion)
  • 6.6. Anti-depressants
    • 6.6.1. Global Cancer Pain Management Market, by Anti-depressants, by Region, 2019-2032 (USD Billion)
  • 6.7. Anti-anxiety drugs
    • 6.7.1. Global Cancer Pain Management Market, by Anti-anxiety drugs, by Region, 2019-2032 (USD Billion)
  • 6.8. Anti-convulsant drugs
    • 6.8.1. Global Cancer Pain Management Market, by Anti-convulsant drugs, by Region, 2019-2032 (USD Billion)
  • 6.9. Nerve Blockers
    • 6.9.1. Global Cancer Pain Management Market, by Nerve Blockers, by Region, 2019-2032 (USD Billion)

7. Global Cancer Pain Management Market, by Cancer Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • 7.3. Lung Cancer
    • 7.3.1. Global Cancer Pain Management Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
  • 7.4. Colorectal cancer
    • 7.4.1. Global Cancer Pain Management Market, by Colorectal cancer, by Region, 2019-2032 (USD Billion)
  • 7.5. Breast cancer
    • 7.5.1. Global Cancer Pain Management Market, by Breast cancer, by Region, 2019-2032 (USD Billion)
  • 7.6. Prostate cancer
    • 7.6.1. Global Cancer Pain Management Market, by Prostate cancer, by Region, 2019-2032 (USD Billion)
  • 7.7. Blood cancer
    • 7.7.1. Global Cancer Pain Management Market, by Blood cancer, by Region, 2019-2032 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Cancer Pain Management Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • 8.3. Immunotherapy
    • 8.3.1. Global Cancer Pain Management Market, by Immunotherapy, by Region, 2019-2032 (USD Billion)
  • 8.4. Chemotherapy
    • 8.4.1. Global Cancer Pain Management Market, by Chemotherapy, by Region, 2019-2032 (USD Billion)
  • 8.5. Radiotherapy
    • 8.5.1. Global Cancer Pain Management Market, by Radiotherapy, by Region, 2019-2032 (USD Billion)
  • 8.6. Home Therapy
    • 8.6.1. Global Cancer Pain Management Market, by Home Therapy, by Region, 2019-2032 (USD Billion)
  • 8.7. Others
    • 8.7.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)

9. Global Cancer Pain Management Market, by End-Use

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 9.3. Hospitals
    • 9.3.1. Global Cancer Pain Management Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 9.4. Cancer Care Clinics
    • 9.4.1. Global Cancer Pain Management Market, by Cancer Care Clinics, by Region, 2019-2032 (USD Billion)
  • 9.5. Others
    • 9.5.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)

10. Global Cancer Pain Management Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Cancer Pain Management Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Cancer Pain Management Market - North America
    • 10.3.1. North America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.3.2. North America: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.3.3. North America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.3.4. North America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.3.5. North America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.3.6. Cancer Pain Management Market - U.S.
      • 10.3.6.1. U.S.: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.3.7. Cancer Pain Management Market - Canada
      • 10.3.7.1. Canada: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.4. Cancer Pain Management Market - Europe
    • 10.4.1. Europe: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.6. Cancer Pain Management Market - UK
      • 10.4.6.1. UK: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.7. Cancer Pain Management Market - France
      • 10.4.7.1. France: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.8. Cancer Pain Management Market - Germany
      • 10.4.8.1. Germany: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.9. Cancer Pain Management Market - Italy
      • 10.4.9.1. Italy: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.10. Cancer Pain Management Market - Spain
      • 10.4.10.1. Spain: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.11. Cancer Pain Management Market - Netherlands
      • 10.4.11.1. Netherlands: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.12. Cancer Pain Management Market - Russia
      • 10.4.12.1. Russia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.5. Cancer Pain Management Market - Asia Pacific
    • 10.5.1. Asia Pacific: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.6. Cancer Pain Management Market - China
      • 10.5.6.1. China: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.7. Cancer Pain Management Market - India
      • 10.5.7.1. India: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.8. Cancer Pain Management Market - Japan
      • 10.5.8.1. Japan: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.9. Cancer Pain Management Market - Malaysia
      • 10.5.9.1. Malaysia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.10. Cancer Pain Management Market - Indonesia
      • 10.5.10.1. Indonesia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.11. Cancer Pain Management Market - South Korea
      • 10.5.11.1. South Korea: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.6. Cancer Pain Management Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.6. Cancer Pain Management Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.7. Cancer Pain Management Market - UAE
      • 10.6.7.1. UAE: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.8. Cancer Pain Management Market - Israel
      • 10.6.8.1. Israel: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.9. Cancer Pain Management Market - South Africa
      • 10.6.9.1. South Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.7. Cancer Pain Management Market - Latin America
    • 10.7.1. Latin America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.7.6. Cancer Pain Management Market - Mexico
      • 10.7.6.1. Mexico: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.7.7. Cancer Pain Management Market - Brazil
      • 10.7.7.1. Brazil: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.7.8. Cancer Pain Management Market - Argentina
      • 10.7.8.1. Argentina: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. BioDelivery Sciences
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Daiichi Sankyo
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Eli Lilly & Company
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Endo Pharmaceuticals
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Johnson & Johnson Inc
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Mallinckrodt Pharmaceuticals
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Pfizer Inc
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Prostrakan Group
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Sanofi S.A.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Teva Pharmaceuticals
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
Show more
Product Code: PM1320

List of Tables

  • Table 1 Global Cancer Pain Management Market, by Pain Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Cancer Pain Management Market, by Drug Type, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Cancer Pain Management Market, by Cancer Type, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Cancer Pain Management Market, by End-Use, by Region, 2019-2032 (USD Billion)
  • Table 5 Global Cancer Pain Management Market, by Application, by Region, 2019-2032 (USD Billion)
  • Table 6 North America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 7 North America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 8 North America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 9 North America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 10 North America: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 11 U.S.: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 13 U.S.: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 14 U.S.: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 15 U.S.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Canada: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 17 Canada: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 18 Canada: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 19 Canada: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 20 Canada: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 21 Europe: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 22 Europe: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 23 Europe: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 24 Europe: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 25 Europe: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Germany: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 27 Germany: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 28 Germany: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 29 Germany: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 30 Germany: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 31 France: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 32 France: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 33 France: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 34 France: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 France: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 36 UK: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 37 UK: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 38 UK: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 39 UK: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 40 UK: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 41 Italy: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 42 Italy: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 43 Italy: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 44 Italy: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 45 Italy: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 46 Netherlands: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 47 Netherlands: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 48 Netherlands: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 49 Netherlands: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 50 Netherlands: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 51 Spain: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 52 Spain: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 53 Spain: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 54 Spain: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 55 Spain: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 56 Russia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 57 Russia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 58 Russia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 59 Russia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 60 Russia: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Asia Pacific: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 62 Asia Pacific: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 63 Asia Pacific: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 64 Asia Pacific: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 65 Asia Pacific: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 66 China: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 67 China: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 68 China: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 69 China: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 70 China: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 71 Japan: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 72 Japan: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 73 Japan: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 74 Japan: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 75 Japan: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 76 India: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 77 India: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 78 India: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 79 India: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 80 India: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 81 Indonesia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 82 Indonesia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 83 Indonesia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 84 Indonesia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 85 Indonesia: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 86 Malaysia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 87 Malaysia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 88 Malaysia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 89 Malaysia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 90 Malaysia: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 91 South Korea: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 92 South Korea: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 93 South Korea: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 94 South Korea: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 95 South Korea: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 96 Latin America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 97 Latin America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 98 Latin America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 99 Latin America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 100 Latin America: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 101 Brazil: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 102 Brazil: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 103 Brazil: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 104 Brazil: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 105 Brazil: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 106 Mexico: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 107 Mexico: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 108 Mexico: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 109 Mexico: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 110 Mexico: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 111 Argentina: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 112 Argentina: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 113 Argentina: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 114 Argentina: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 115 Argentina: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 116 Middle East & Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 117 Middle East & Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 118 Middle East & Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 119 Middle East & Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 120 Middle East & Africa: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 121 UAE: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 122 UAE: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 123 UAE: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 124 UAE: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 125 UAE: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 126 Saudi Arabia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 127 Saudi Arabia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 128 Saudi Arabia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 129 Saudi Arabia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 130 Saudi Arabia: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 131 South Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 132 South Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 133 South Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 134 South Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 135 South Africa: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 136 Israel: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 137 Israel: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 138 Israel: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 139 Israel: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 140 Israel: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cancer Pain Management Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Pain Type
  • Figure 7. Global Cancer Pain Management Market, by Pain Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Cancer Pain Management Market, by Drug Type, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Cancer Type
  • Figure 11. Global Cancer Pain Management Market, by Cancer Type, 2021 & 2030 (USD Billion)
  • Figure 12. Market by End-Use
  • Figure 13. Global Cancer Pain Management Market, by End-Use, 2021 & 2030 (USD Billion)
  • Figure 14. Market by Application
  • Figure 15. Global Cancer Pain Management Market, by Application, 2021 & 2030 (USD Billion)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!